Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Income Statement
Earnings Waterfall
Phathom Pharmaceuticals Inc
Revenue
|
682k
USD
|
Cost of Revenue
|
-167k
USD
|
Gross Profit
|
515k
USD
|
Operating Expenses
|
-167.8m
USD
|
Operating Income
|
-167.3m
USD
|
Other Expenses
|
-34.3m
USD
|
Net Income
|
-201.6m
USD
|
Income Statement
Phathom Pharmaceuticals Inc
Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
|
Gross Profit | ||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
|
Operating Income | ||||||||||||||||||||
Operating Expenses |
(85)
|
(91)
|
(106)
|
(125)
|
(62)
|
(89)
|
(126)
|
(139)
|
(154)
|
(154)
|
(135)
|
(141)
|
(151)
|
(159)
|
(172)
|
(165)
|
(151)
|
(144)
|
(168)
|
|
Selling, General & Administrative |
(3)
|
(4)
|
(7)
|
(11)
|
(14)
|
(20)
|
(28)
|
(36)
|
(45)
|
(54)
|
(63)
|
(70)
|
(83)
|
(90)
|
(101)
|
(99)
|
(92)
|
(92)
|
(118)
|
|
Research & Development |
(82)
|
(87)
|
(99)
|
(115)
|
(48)
|
(69)
|
(98)
|
(103)
|
(110)
|
(100)
|
(72)
|
(69)
|
(67)
|
(69)
|
(71)
|
(65)
|
(59)
|
(52)
|
(50)
|
|
Operating Income |
(85)
N/A
|
(91)
-7%
|
(106)
-17%
|
(125)
-18%
|
(62)
+50%
|
(89)
-43%
|
(126)
-41%
|
(139)
-11%
|
(154)
-11%
|
(154)
0%
|
(135)
+13%
|
(141)
-5%
|
(151)
-7%
|
(159)
-5%
|
(172)
-9%
|
(165)
+5%
|
(151)
+8%
|
(144)
+5%
|
(167)
-16%
|
|
Pre-Tax Income | ||||||||||||||||||||
Interest Income Expense |
(1)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(5)
|
(5)
|
(5)
|
(7)
|
(8)
|
(13)
|
(20)
|
(25)
|
(30)
|
(34)
|
(33)
|
(34)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(4)
|
(64)
|
(146)
|
(146)
|
(142)
|
(82)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(90)
N/A
|
(158)
-76%
|
(255)
-62%
|
(274)
-7%
|
(207)
+24%
|
(173)
+16%
|
(129)
+26%
|
(144)
-11%
|
(159)
-11%
|
(162)
-2%
|
(144)
+11%
|
(150)
-4%
|
(164)
-10%
|
(179)
-9%
|
(198)
-11%
|
(195)
+1%
|
(185)
+5%
|
(177)
+4%
|
(202)
-14%
|
|
Net Income | ||||||||||||||||||||
Income from Continuing Operations |
(90)
|
(158)
|
(255)
|
(274)
|
(207)
|
(173)
|
(129)
|
(144)
|
(159)
|
(162)
|
(144)
|
(150)
|
(164)
|
(179)
|
(198)
|
(195)
|
(185)
|
(177)
|
(202)
|
|
Net Income (Common) |
(90)
N/A
|
(158)
-76%
|
(255)
-62%
|
(274)
-7%
|
(207)
+24%
|
(173)
+16%
|
(129)
+26%
|
(144)
-11%
|
(159)
-11%
|
(162)
-2%
|
(144)
+11%
|
(150)
-4%
|
(164)
-10%
|
(179)
-9%
|
(198)
-11%
|
(195)
+1%
|
(185)
+5%
|
(177)
+4%
|
(202)
-14%
|
|
EPS (Diluted) |
-3.47
N/A
|
-6.42
-85%
|
-10.32
-61%
|
-10.89
-6%
|
-8.09
+26%
|
-6.68
+17%
|
-3.88
+42%
|
-4.97
-28%
|
-5.45
-10%
|
-5.38
+1%
|
-4.72
+12%
|
-3.93
+17%
|
-4.28
-9%
|
-4.59
-7%
|
-5.05
-10%
|
-4.6
+9%
|
-3.81
+17%
|
-3.11
+18%
|
-3.93
-26%
|